Will this trial change my practice? | Proceedings of EuroPCR

Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study – 12 or 30 months of dual antiplatelet therapy after drug-eluting stents

EuroIntervention 2015;11:364-365. DOI: 10.4244/EIJV11I3A71

Maik J. Grundeken
Maik J. Grundeken1, MD; Alexandra Lansky2, MD; Jean-Francois Tanguay3, MD; Anthony Gershlick4, MD; Andreas Baumbach5*, MD; Thomas Cuisset6, MD, PhD
1. University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands; 2. Yale University School of Medicine, Yale New Haven Hospital, New Haven, CT, USA; 3. Université de Montreal, Montreal Heart Institute, Montreal, Canada: 4. Department of Ca
The “Will this trial change my practice?” sessions at PCR

The aim of the article is to capture the session at EuroPCR 2015, communicate the analysis of the trialists, and report the views expressed in the interactive discussion.


ACS: acute coronary syndrome

BMS: bare metal stent

DAPT: dual antiplatelet therapy

DES: drug-eluting stent

ESC: European Society of Cardiology

HCRI: Harvard Clinical Research Institute

LAD: left anterior descending artery

LCx: left circumflex artery

LM: left main coronary artery

MACCE: major cardiac and cerebrovascular events

MI: myocardial infarction


Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease)

Latest news